| Common Patient Concerns About the Use of Glucagon-like Peptide-1 Receptor Agonists in Diabetes Mellitus Management. | |
| | |
MedLine Citation:
|
PMID: 22267301 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The authors present a case of a 46-year-old woman with type 2 diabetes mellitus who has been on a treatment regimen involving diet, exercise, and metformin. After 2 years of treatment, she has a body mass index of 35 and a glycosylated hemoglobin level of 8.0%, and this level is increasing. Her physician recommends adding a glucagon-like peptide-1 (GLP-1) receptor agonist to her treatment regimen, prompting her to ask several questions. The authors present these questions along with proposed answers, highlighting the practical application of GLP-1 receptor agonists in the context of common patient concerns. |
| | |
Authors:
|
Jeffrey S Freeman; James R Gavin; Craig W Spellman |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The Journal of the American Osteopathic Association Volume: 112 ISSN: 1945-1997 ISO Abbreviation: J Am Osteopath Assoc Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-01-23 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7503065 Medline TA: J Am Osteopath Assoc Country: United States |
Other Details:
|
Languages: eng Pagination: S22-4 Citation Subset: IM |
Affiliation:
|
4190 City Ave, Suite 324, Division of Endocrinology and Metabolism, Philadelphia College of Osteopathic Medicine, Philadelphia, PA 19131-1633. jeffreyfreemando@aol.com. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Improving Glucagon-like Peptide-1 Dynamics in Patients With Type 2 Diabetes Mellitus.
Next Document: Incorporating Glucagon-like Peptide-1 Receptor Agonists Into Clinical Practice.